5Abushulaih S, Ssad ED, Munsell M, et al. Incidence and severity of hand foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience [J]. Cancer Invest 2002,20(1):3-10.
6Joan D. Webster-Gandya, Chris Howa, K et al.Palmar - plantar erythrodysesthesia (PPE): A fiterature review with commentary on experience in a cancer centre[J].European Journal of Oncology Nursing (2007) 11,238-246
7Jacobi U,Waibler E, Schuhe P, et al. Release of doxorubicin in sweat:first step to induce the palmar-plantar erythrodysesthesia syndrome?[J].The European Society for Medical Oncology,2005, 16(7):1210-1211
8Mary E, Gordinier, Don S, et al.Elevated body mass index does not increase the risk of palmar - plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin[J], Gynecologic Oncology,2006,106:72 - 74
9Lin E, Morris js, Ayers GD.Effect of celecoxib on capecitabine-induced hand-- foot syndrome and antitumor activity[J].Oncology(Williston Park), 2002, 16(12 SupplNo 14):31- 37
10Samer Abushullaih, M.D,Everardo D, et al. Incidence and Severity of Hand-Foot.Syndrome in Colorectal Cancer Patients Treated with Capecitabine: A Single-institution Experience.Cancer Investigation[J].002, 20(1), 3-10
7STATHOPOULOS GP, ANTONIOU D, DIMITROULIS J, et al.Liposomal cis- platin combined with paclitaxel versus cisplatin and paclitaxel in non- small-cell lung cancer: a randomized phase Ⅲ multicanter trial [J]. Ann 0ncol,2010,21(11) : 2227 - 2232.
8BOULIKAS T,MYLONAKIS N,ATHANASIOU A,et al. Liposomally-en- capsulated cisplatin (Lipoplatin) plus gemcitabine in NSCLC: preliminary results of a phase Ⅱ trial and its antiangiogenesis potemial[J].Clin Oncol, 2008,26(15) : 1421 - 1429.
10Samer Abushullaih,Everardo D. Saad,Mark Munsell,Paulo M. Hoff.Incidence and Severity of Hand–Foot Syndrome in Colorectal Cancer Patients Treated with Capecitabine: A Single-Institution Experience[J].Cancer Investigation.2002(1)
